TrialPanorama/Dataset huggingface dataset:
Please assess the completion status of the following clinical trial:

Trial Title: Baby Bump Lifestyle Intervention Supplement Study

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: SINGLE
- Phase: None
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Pregnant woman presenting to her first obstetrical visit for this pregnancy~* Must be in the first trimester (\<13 weeks)~* 18 years or older~* High-stress levels as measured by the Perceived Stress Level Questionnaire~* Must be a single pregnancy (e.g. not twins, triplets, etc.)~Exclusion Criteria:~* Diabetes (types 1 and 2)~* Diagnosis of gestational diabetes in prior pregnancy~* Hyperemesis gravidarum or severe morning sickness that interferes with supplement intake~* Major medical illnesses including but not limited to: malabsorption syndromes (Celiac's disease, Crohn's, Ulcerative Colitis), Systemic Lupus Erythematosus and other major autoimmune conditions

- Gender: FEMALE
- Minimum Age: 18 Years
- Maximum Age: 40 Years
- Healthy Volunteers: t

Study Arms:
- Placebo (Type: PLACEBO_COMPARATOR): placebo supplement
- Supplement (Type: EXPERIMENTAL): actual supplement

Based on this trial design, predict the completion outcome and termination type (if applicable).

Answer: outcome: terminate
termination_type: regulatory/approval
Please assess the completion status of the following clinical trial:

Trial Title: Comparison of Embryo Transfer in Egg Donation Recipients With Transvaginal and Transabdominal Ultrasound

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: EARLY_PHASE1
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Patients undergoing oocyte donation treatment with transfer of 2 embryos on day 3~Exclusion Criteria:~* Submucous or \>3 cm intramural fibroids~* Turner syndrome~* Black recipients

- Gender: FEMALE
- Minimum Age: 18 Years
- Maximum Age: 49 Years
- Healthy Volunteers: f

Study Arms:
- Transvaginal ultrasound-guided embryo transfer (Type: EXPERIMENTAL): Transvaginal ultrasound-guided transfer of two day-3 embryos
- Transabdominal ultrasound-guided embryo transfer (Type: ACTIVE_COMPARATOR): Transabdominal ultrasound-guided transfer of two day-3 embryos

Based on this trial design, predict the completion outcome and termination type (if applicable).

Answer: outcome: terminate
termination_type: enrollment issues
Please assess the completion status of the following clinical trial:

Trial Title: Treatment Strategy for Low-grade Gliomas

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: PHASE3
- Number of Arms: 4.0

Eligibility Criteria:
Inclusion Criteria:~* Histologically confirmed newly diagnosed low-grade gliomas~* Karnofsky performance status of 60 or more~Exclusion Criteria:~* Previous history of radiation therapy or chemotherapy for gliomas~* Pregnant or breast feeding~* Diagnosis of another malignancy may exclude subject from study~* Evidence or history of bleeding diathesis~* Evidence or history of hypersensitivity to temozolomide

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 60 Years
- Healthy Volunteers: f

Study Arms:
- Total resection with early radiation (Type: EXPERIMENTAL): Total resected LGGs treated with early radiation
- Total resection without radiation (Type: NO_INTERVENTION): Total resected LGGs treated without radiation
- Residual LGGs with radiation (Type: EXPERIMENTAL): Residual LGGs treated with early radiation
- Residual LGGs with chemo (Type: EXPERIMENTAL): Residual LGGS treated with temozolomide

Based on this trial design, predict the completion outcome and termination type (if applicable).

Answer: outcome: terminate
termination_type: enrollment issues
Please assess the completion status of the following clinical trial:

Trial Title: Trial of Magnesium Sulfate Tocolysis Versus Nifedipine Tocolysis in Women With Preterm Labor

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: TRIPLE
- Phase: None
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Women in preterm labor between 24 to 32 6/7 weeks' gestation with intact membranes with an age range of 15 to 50 years old.~Exclusion Criteria:~* Cervical dilatation of ≥ 6 cm~* Maternal contraindication to tocolysis~* Known fetal anomalies~* Suspected chorioamnionitis~* Nonreassuring fetal heart tracing~* Vaginal bleeding due to placenta previa or abruptio placenta~* Preterm premature rupture of membranes~* Prolapsed membranes~* Human immunodeficiency virus positive~* Multiple gestation~* Patients on procardia within 24 hours of po intake~* Magnesium sulfate tocolysis prior to randomization~* Patient refusal

- Gender: FEMALE
- Minimum Age: 15 Years
- Maximum Age: 50 Years
- Healthy Volunteers: t

Study Arms:
- 1 (Type: ACTIVE_COMPARATOR): Intravenous magnesium sulfate or placebo
- 2 (Type: ACTIVE_COMPARATOR): Oral nifedipine or placebo

Based on this trial design, predict the completion outcome and termination type (if applicable).

Answer: outcome: terminate
termination_type: enrollment issues
Please assess the completion status of the following clinical trial:

Trial Title: Reducing Barriers to Behavior Change Among Youth With Pediatric Overweight and Obesity

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: None
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* patient age 8-17 years~* patient with public insurance managed by Children's Community Health Network~* English speaking patient and parent~* patient body mass index at or above the 85th percentile for age and sex~* parent or legal guardian willing to participate~Exclusion Criteria:~* significant patient developmental or cognitive delay~* concurrent involvement in another formal weight management program.

- Gender: ALL
- Minimum Age: 8 Years
- Maximum Age: 17 Years
- Healthy Volunteers: f

Study Arms:
- 1 (Type: ACTIVE_COMPARATOR): Multifamily group weight management intervention plus rewards for program attendance
- 2 (Type: ACTIVE_COMPARATOR): Multifamily group weight management intervention plus rewards for attendance and goal attainment

Based on this trial design, predict the completion outcome and termination type (if applicable).

Answer: outcome: terminate
termination_type: enrollment issues
Please assess the completion status of the following clinical trial:

Trial Title: Fenofibrate and Metformin Insulin Sensitivity in Type 2 Diabetics Study

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: QUADRUPLE
- Phase: PHASE2/PHASE3
- Number of Arms: 4.0

Eligibility Criteria:
Inclusion Criteria:~* Patients with type 2 diabetes mellitus and dyslipidemia.~Exclusion Criteria:~* Type 1 diabetes.

- Gender: ALL
- Minimum Age: 40 Years
- Maximum Age: 75 Years
- Healthy Volunteers: f

Study Arms:
- 1 (Type: EXPERIMENTAL): None
- 2 (Type: ACTIVE_COMPARATOR): None
- 3 (Type: ACTIVE_COMPARATOR): None
- 4 (Type: PLACEBO_COMPARATOR): None

Based on this trial design, predict the completion outcome and termination type (if applicable).

Answer: outcome: terminate
termination_type: enrollment issues
Please assess the completion status of the following clinical trial:

Trial Title: Neurotoxic Adverse Effects of Morphine and Oxycodone for Pain in Terminal Patients With Diminished Renal Function

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: SUPPORTIVE_CARE
- Time Perspective: None
- Masking: DOUBLE
- Phase: PHASE4
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* minimal age of 18 years at the time of inclusion;~* the subject is in the terminal phase, i.e. death in the near future is expected by the treating physician;~* start of CSCI with an opioid for treatment of pain is indicated by the treating physician;~* willingness to allow one-time blood collection for assessment of renal function (eGFR);~* a signed informed consent is given by the participant or his/her legal representative.~Exclusion Criteria:~* delirium at the time of inclusion;~* opioid induced hyperalgesia (OIH) at the time of inclusion;~* a medical necessity to apply a different opioid than morphine or oxycodone, such as previously demonstrated non-response to morphine or oxycodone (defined as a complete absence of any pain reduction after appropriate dosage), previously demonstrated unacceptable side effects of morphine or oxycodone, or a medical indication for an opioid with NMDA-receptor-antagonistic properties (currently only known for methadone);~* a documented allergy for morphine or oxycodone.~Subjects with an eGFR \>50 ml/min/1.73m2 should not be included in the study, because accumulation of metabolites is considered to be irrelevant in this range of renal functions. Despite this fact, we cannot formulate an unaffected renal function as an exclusion criterion prior to allocation, because the time needed for assessment of the renal function could lead to either an unethical delay in treatment of pain or occurrence of death even before the lab results are known. Therefore renal function is assessed after inclusion. In case a subject turns out to exceed the threshold of 50 ml/min/1.73m2, this will be considered as meeting an extended exclusion criterion and the subject concerned will be replaced by a new subject.

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- Oxycodone (Type: EXPERIMENTAL): Continuous subcutaneous infusion (CSCI) of oxycodone.
- Morphine (Type: ACTIVE_COMPARATOR): Continuous subcutaneous infusion (CSCI) of morphine.

Based on this trial design, predict the completion outcome and termination type (if applicable).

Answer: outcome: terminate
termination_type: enrollment issues
Please assess the completion status of the following clinical trial:

Trial Title: Safety and Preliminary Efficacy of Combination Therapy for the Treatment of Acne Vulgaris

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: None
- Number of Arms: 3.0

Eligibility Criteria:
Inclusion Criteria:~* Have mild to moderate facial acne~* Have Fitzpatrick skin type II-V~* Be able to understand written and/or spoken English~* Be able to provide written informed consent.~Exclusion Criteria:~* Have been treated with oral retinoids in the past 6 months~* Have been treated with oral antibiotic within the last 30 days~* Have received topical acne treatment (i.e. retinoids, antibiotics and anti-inﬂammatory agents or chemical peeling) within the last 30 days~* Pregnant or lactating~* Have history of photo-sensitive dermatitis~* Have previously received light therapy~* Taking oral contraceptive pills (OCP)~* Have pacemaker

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 30 Years
- Healthy Volunteers: f

Study Arms:
- BLP arm (Blue Light Phototherapy) (Type: ACTIVE_COMPARATOR): In this arm participants will receive 5 BLP sessions at 1 week intervals. The duration of each session will be approximately 20 minutes. At each session, the affected areas of the participant's face will be exposed to a light source using blue light phototherapy machine between 15 to 20 minutes.
- MCT arm (Microcurrent Therapy) (Type: ACTIVE_COMPARATOR): In this arm participants will receive 5 MCT sessions 1 week intervals using MCT machine. The duration of each session will be approximately 45 minutes. The investigators will place one electrode in one of the regional areas of the lymph nodes or affected area (i.e. the forehead) and move the second electrode systematically from the affected area towards the stationary electrode. Once the entire affected area has been covered, the investigators will move the first electrode to another regional area of the lymph nodes or affected area and the process will be repeated. This will continue until all of the affected areas have been treated.
- Combination of BLP and Microcurrent (Type: ACTIVE_COMPARATOR): In this arm participants will receive 5 BLP and 5 MCT sessions at 1 week intervals. At each session, participants will receive MCT portion as described in above followed by BLP portion as described above. These visits will last approximately 65 minutes.

Based on this trial design, predict the completion outcome and termination type (if applicable).

Answer: outcome: terminate
termination_type: enrollment issues
Please assess the completion status of the following clinical trial:

Trial Title: Efficacy of Non-Invasive Mechanical Ventilation in Early Hypoxia Secondary to Thoracic Trauma

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: PREVENTION
- Time Perspective: None
- Masking: NONE
- Phase: PHASE4
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Age \> 18 years.~* Informed consent obtained.~* pO2/FiO2 \<200 for more than 8 consecutive hours in the first 48 hours after thoracic trauma.~Exclusion Criteria:~* Orotracheal intubation indicated for any other reason.~* Standard contraindication for non-invasive ventilation (active gastro-intestinal haemorrhage, low level of consciousness, multiorgan failure, airway control problems, lack of cooperation, hemodynamic instability).~* Severe traumatic brain injury.~* Facial trauma with pneumocephalus, skull base fracture, orbit base fracture, any facial fracture involving a sinus.~* Cervical injury with specific treatment contraindicating a facial mask.~* Bronco-pleural fistula.~* Gastro-intestinal trauma.

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- 1 (Type: ACTIVE_COMPARATOR): Addition to the standard therapy of non-invasive mechanical ventilation. Continuously for the first 24 hours, then trials to discontinuation every 24 hours. Interface adjusted for the associated injuries.
- 2 (Type: NO_INTERVENTION): Standard therapy for severe post-traumatic hypoxia: pain control with epidural anesthesia and oxygen.

Based on this trial design, predict the completion outcome and termination type (if applicable).

Answer: outcome: terminate
termination_type: lack of efficacy
Please assess the completion status of the following clinical trial:

Trial Title: EuroPainClinics® Study I (Prospective Trial)

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: QUADRUPLE
- Phase: None
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Age of 18 years or older~* Written informed consent~* Herniated disc, nerve compression, radicular syndromes (vertebrogenic algic syndrome)~* magnetic resonance examination evidence of intervertebral disc herniation~* Pain radiating to the lower limbs~* Disc lesion one level higher than dermatome with pain symptoms~Exclusion Criteria:~* Patients not capable of consenting~* pregnant women or women of child-bearing potential~* Previous spine operations~* Protrusion of more than one intervertebral disc~* Cauda equine syndrome

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- Group A (Type: EXPERIMENTAL): 1x periradicular therapy in one intervertebral space, corresponding with pain radiating dermatome
- Group B (Type: EXPERIMENTAL): 2x periradicular therapy in two intervertebral spaces, the first corresponding with pain radiating dermatome the second according magnetic resonance visualization where stenosis is situated

Based on this trial design, predict the completion outcome and termination type (if applicable).

Answer: outcome: terminate
termination_type: lack of efficacy
Please assess the completion status of the following clinical trial:

Trial Title: The Impact of Three Distinct Exercise Types on Fatigue, Anxiety, and Depression in Parkinson's Disease

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: None
- Number of Arms: 4.0

Eligibility Criteria:
Inclusion Criteria:~1. Subjects diagnosed with Idiopathic Parkinson's Disease~2. Age between 18 - 75 years~3. Hoehn and Yahr stage less than or equal to 3~4. Mini-Mental State Exam (MMSE) score of over 23 at screening~5. If subjects are taking any medications for depression, fatigue, or anxiety, regimen must be stable for 8 weeks prior to baseline visit~6. Subjects willing and able to give informed consent~Exclusion Criteria:~1. Subjects with a diagnosis of an atypical Parkinsonism~2. Subjects unwilling or unable to obtain Health Waiver from Primary Care Provider~3. Score of 60 or more on UPDRS III at screening~4. Scores in the 'normal' range on all three study assessments: Beck Depression Index II, Fatigue Severity Scale, and Zung self-rating Anxiety Scale~5. Participation in any of the 3 physical activities more than 3 times in the past for 8 weeks prior to baseline~6. Any other reason that, in the investigator's opinion, would exclude the subject from participation in the study

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 75 Years
- Healthy Volunteers: f

Study Arms:
- Spinning Class (Type: EXPERIMENTAL): Subjects randomly selected for the spinning group will participate in spinning classes, twice a week for six weeks. Subjects will complete questionnaires at screening, each week during the class sessions, and for 1 month follow-up.
- Yoga Class (Type: EXPERIMENTAL): Subjects randomly selected for the yoga group will participate in yoga classes, twice a week for six weeks. Subjects will complete questionnaires at screening, each week during the class sessions, and for 1 month follow-up.
- Dance Class (Type: EXPERIMENTAL): Subjects randomly selected for the dance group will participate in dance classes, twice a week for six weeks. Subjects will complete questionnaires at screening, each week during the class sessions, and for 1 month follow-up.
- No Exercise Class (Type: ACTIVE_COMPARATOR): Subjects randomly selected for the no class group will not participate in the study exercise classes. Subjects will still complete questionnaires at screening, each week during the class sessions, and for 1 month follow-up.

Based on this trial design, predict the completion outcome and termination type (if applicable).

Answer: outcome: terminate
termination_type: enrollment issues
Please assess the completion status of the following clinical trial:

Trial Title: Early Standardized Weight Bearing Utilizing Immersion Therapy Following Periarticular Lower Extremity Fractures

Study Design Characteristics:
- Allocation: None
- Intervention Model: None
- Observational Model: CASE_CONTROL
- Primary Purpose: None
- Time Perspective: PROSPECTIVE
- Masking: None
- Phase: None
- Number of Arms: None

Eligibility Criteria:
Inclusion Criteria:~* Inclusion criteria for the patient population under study consists of both male and female adults, at least 18 years old, who are treated for periarticular fractures of the lower extremity. The periarticular fractures included in this study will be: acetabular, tibial plateau, tibial plafond fractures.~Exclusion Criteria:~* Age \<18 years~* Wound complications deemed to be unsafe for immersion.~* Multiple extremity articular fractures~* Other injuries that preclude their safe participation in physical therapy.

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- Immersion Therapy- Study (Type: None): 1. Patients who participate in the immersion therapy post-operative protocol and begin progressive weight bearing at 4 weeks (study)
- Control Group (Type: None): 2. Patients who undergo the traditional 10-week non-weight bearing post-operative care protocol (control)

Based on this trial design, predict the completion outcome and termination type (if applicable).

Answer: outcome: terminate
termination_type: lack of efficacy
Please assess the completion status of the following clinical trial:

Trial Title: Evaluation of a Personalized Normative Feedback Repeatedly Delivered Via a Mobile Application After a Brief Therapeutic Intervention on Alcohol-related Risks:

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: OTHER
- Time Perspective: None
- Masking: NONE
- Phase: None
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Aged 18-26 years;~* Admitted for an acute alcohol intoxication to the ED from Thursday to Sunday;~* Need to be kept in the ED for detoxification;~* Alcohol breath test or blood alcohol concentration if breath test impossible greater than 0.5 gram per liter at the admission to the ED;~* Able to understand and remember the component of the study;~* Use of a smartphone;~* Written informed consent.~Exclusion Criteria:~* Patients in police custody and not admitted to emergency;~* Patients admitted for suicidal ideation or attempt;~* Injury requiring an hospitalization;~* Additional need for psychiatric or addiction evaluation;~* Current care in addiction facilities (last contact less than 3 months);~* Planning of a specialized care at the end of the hospitalization;~* Persons participant to major legal protection (safeguarding justice, guardianship, trusteeship), persons deprived of liberty.~* Patients participating in another interventional research

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 26 Years
- Healthy Volunteers: f

Study Arms:
- Personalized Normative Feedback group (Type: EXPERIMENTAL): A personalized normative feedback using a tablet application will be performed after the BTI at ED. The application installed on the patient's smartphone will automatically repeat the PNF, using a local algorithm, once a month over a 6-months period after discharge, and once every two months in the following 6-month period. It will be also possible to perform the PNF on the server website.
- Control group (Type: OTHER): The control group will not receive further counseling or information after the baseline BTI at ED. The application installed in this group will be only used for the evaluation questionnaire at 6 and 12 months

Based on this trial design, predict the completion outcome and termination type (if applicable).

Answer: outcome: terminate
termination_type: lack of efficacy